Back to feed

Oncology

ONS guidance, chemo safety, neutropenia, and symptom care.

What this unit follows

ONS guidanceChemotherapy safetyNeutropeniaSymptom managementPain managementPalliative care

Evidence trust guarantee: Articles are gathered from trusted clinical, nursing, public health, and research sources. NurseJet summarizes key points for quick review, but nurses should verify details against the original source and follow facility-specific protocols before changing practice.

Latest for Oncology (3)

Clinical GuidelineSource verified

Clinical guidance on neutropenic sepsis (NICE CG151) reinforces that febrile neutropenia — a fever in a patient with a low absolute neutrophil count (ANC) after chemotherapy — is an oncologic emergency. Because neutropenic patients can't mount a normal inflammatory response, infection can progress to sepsis quickly with few classic signs.

The guidance stresses early recognition and rapid response: assess for fever and any source of infection, draw cultures, and support prompt initiation of empiric antibiotics, often within an hour of presentation. Subtle changes — a single temperature, new malaise, or mild hypotension — can be the only warning.

Why this matters on shift

Neutropenic patients can go from a single fever to septic shock fast, and the usual warning signs may be muted. Nurses who know who is at nadir and treat a fever as time-critical can trigger the rapid antibiotics that change outcomes.

Practice AlertSource verified

CDC guidance on preventing intravascular catheter-related bloodstream infections reminds critical-care teams that insertion and maintenance practices both matter. The guidance addresses hand hygiene, maximal sterile barriers at insertion, chlorhexidine skin antisepsis, site selection, and — most relevant to bedside nurses — ongoing assessment of line necessity.

The bundle is built on evidence that consistent maintenance care, not just a clean insertion, drives infection rates. The alert emphasizes scrubbing the hub for the recommended time before every access, keeping dressings clean, dry, and intact, and removing any line the moment it is no longer needed. CLABSI carries meaningful mortality and added length of stay, so each prevented infection matters.

Why this matters on shift

CLABSIs are largely preventable, costly, and dangerous. Nurses are the constant at the bedside, so the maintenance steps you own — hub disinfection, dressing checks, and championing early line removal — are where most CLABSI prevention actually happens.

Clinical GuidelineSource verified

ONS guidance on chemotherapy and biotherapy administration reinforces the safe-handling and vesicant-management practices that protect both patients and nurses. Vesicants can cause severe tissue injury if they leak into surrounding tissue, so prevention, early recognition, and a prepared response are emphasized.

The guidance covers verifying a patent vascular access device, monitoring the site during administration, recognizing extravasation early (burning, swelling, loss of blood return, or resistance), and following a defined response: stop the infusion, aspirate, and apply the antidote or thermal measure appropriate to the agent.

Why this matters on shift

Extravasation can cause lasting tissue damage, but most harm is preventable with vigilant monitoring and a fast, correct response. Oncology nurses control the access checks, site monitoring, and immediate response that determine the outcome.